According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,73ย โฌ. In 2021 the company made an earnings per share (EPS) of -2,49ย โฌ an increase over its 2020 EPS that were of -4,00ย โฌ.